Canngea to construct pharmaceutical grade facility to grow and manufacture medical cannabis products

Updated November 23 2019 - 7:14am, first published November 22 2019 - 9:58am

Australian startup Canngea is keen to address the global shortage of medical cannabis, setting up Australia's largest pharmaceutical grade indoor facility to grow and manufacture high quality cannabis products.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Singleton news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.